AMGEN at American Oncology

Amgen is proud to be a part of the 2021 ASCO Annual Meeting. While you’re here, you can explore the latest scientific information and disease state education. Additionally, you can learn about Amgen’s long-term commitment to developing and delivering transformative medicines for oncology patients.

Amgen Data

From disease state education to breaking news on clinical trials, Amgen is making an impact on the oncology landscape.

You CAN Learn More
about amgen data here

Reference: 1. Biernacka A, et al. Cancer Genet. 2016;209:195-198.